• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性肉芽肿性乳腺炎:根据伊朗 374 例患者疾病严重程度寻找最有效且副作用最小的治疗方法。

Idiopathic granulomatous mastitis: Looking for the most effective therapy with the least side effects according to the severity of the disease in 374 patients in Iran.

机构信息

Tehran University of Medical Sciences, Tehran, Iran.

Breast Disease Research Centre, TUMS, Tehran, Iran.

出版信息

Breast J. 2019 Jul;25(4):672-677. doi: 10.1111/tbj.13300. Epub 2019 May 13.

DOI:10.1111/tbj.13300
PMID:31087459
Abstract

The goal of this study is to compare the response rate and the recurrence rate of available therapeutic modalities in the treatment of Idiopathic Granulomatous Mastitis (IGM). 374 patients with pathologically confirmed IGM, were included. They were subdivided into three levels of severity. Close observation had the best response rate with the lowest recurrence rate in mild to moderate cases. Severe cases were mostly treated by prednisolone or underwent surgery. The outcome of prednisolone use in severe cases was comparable to NSAIDs. Overall 9% were resistant to treatment and surgical intervention is still an option among them.

摘要

本研究旨在比较特发性肉芽肿性乳腺炎(IGM)各种治疗方法的应答率和复发率。共纳入 374 例经病理证实的 IGM 患者,将其分为 3 个严重程度级别。在轻中度病例中,密切观察的应答率最高,复发率最低。严重病例大多采用泼尼松龙治疗或手术治疗。严重病例中泼尼松龙的使用效果与 NSAIDs 相当。总体而言,有 9%的患者对治疗无反应,手术干预仍然是其中一种选择。

相似文献

1
Idiopathic granulomatous mastitis: Looking for the most effective therapy with the least side effects according to the severity of the disease in 374 patients in Iran.特发性肉芽肿性乳腺炎:根据伊朗 374 例患者疾病严重程度寻找最有效且副作用最小的治疗方法。
Breast J. 2019 Jul;25(4):672-677. doi: 10.1111/tbj.13300. Epub 2019 May 13.
2
Corticosteroid treatment in the management of idiopathic granulomatous mastitis to avoid unnecessary surgery.皮质类固醇治疗在特发性肉芽肿性乳腺炎管理中的应用,以避免不必要的手术。
Surg Today. 2015 Apr;45(4):457-65. doi: 10.1007/s00595-014-0966-5. Epub 2014 Jul 4.
3
Steroids administered after vacuum-assisted biopsy in the management of idiopathic granulomatous mastitis.真空辅助活检后给予类固醇治疗特发性肉芽肿性乳腺炎。
J Clin Pathol. 2017 Oct;70(10):827-831. doi: 10.1136/jclinpath-2016-204287. Epub 2017 Mar 17.
4
Corticosteroid treatment and timing of surgery in idiopathic granulomatous mastitis confusing with breast carcinoma.特发性肉芽肿性乳腺炎与乳腺癌的皮质类固醇治疗和手术时机。
Breast Cancer Res Treat. 2010 Sep;123(2):447-52. doi: 10.1007/s10549-010-1041-6. Epub 2010 Jul 13.
5
Idiopathic granulomatous mastitis: challenges of treatment in iranian women.特发性肉芽肿性乳腺炎:伊朗女性治疗面临的挑战。
BMC Surg. 2021 Apr 21;21(1):206. doi: 10.1186/s12893-021-01210-6.
6
Conservative management for idiopathic granulomatous mastitis mimicking carcinoma: case reports and literature review.模仿癌的特发性肉芽肿性乳腺炎的保守治疗:病例报告及文献综述
Breast Dis. 2010;31(1):57-60. doi: 10.3233/BD-2009-0294.
7
Management of idiopathic granulomatous mastitis in lactation: case report and review of the literature.哺乳期特发性肉芽肿性乳腺炎的治疗:病例报告及文献复习。
Int Breastfeed J. 2021 Mar 4;16(1):23. doi: 10.1186/s13006-021-00370-8.
8
Comparison of the Outcome of Low Dose and High-Dose Corticosteroid in the Treatment of Idiopathic Granulomatous Mastitis.对比小剂量和大剂量皮质类固醇治疗特发性肉芽肿性乳腺炎的疗效。
Asian Pac J Cancer Prev. 2020 Apr 1;21(4):993-996. doi: 10.31557/APJCP.2020.21.4.993.
9
Idiopathic ganulomatous mastitis.特发性肉芽肿性乳腺炎
BMJ Case Rep. 2012 Nov 27;2012:bcr2012006187. doi: 10.1136/bcr-2012-006187.
10
Management of idiopathic granulomatous mastitis diagnosed by core biopsy: a retrospective multicenter study.经核心活检诊断的特发性肉芽肿性乳腺炎的治疗:一项回顾性多中心研究。
Breast J. 2013 Jul-Aug;19(4):411-8. doi: 10.1111/tbj.12123. Epub 2013 May 12.

引用本文的文献

1
Analysis of three treatment methods for granulomatous lobular mastitis: a retrospective study in a single center.肉芽肿性小叶性乳腺炎三种治疗方法的分析:一项单中心回顾性研究
Front Oncol. 2025 Apr 30;15:1588836. doi: 10.3389/fonc.2025.1588836. eCollection 2025.
2
Predisposing Factors for Idiopathic Granulomatous Mastitis: A Large Prospective Multicentric Study.特发性肉芽肿性乳腺炎的诱发因素:一项大型前瞻性多中心研究
Iran J Public Health. 2025 Mar;54(3):645-653. doi: 10.18502/ijph.v54i3.18258.
3
A new stage for predicting the prognosis of granulomatous lobular mastitis.
预测肉芽肿性小叶性乳腺炎预后的新阶段。
PLoS One. 2025 Mar 19;20(3):e0319956. doi: 10.1371/journal.pone.0319956. eCollection 2025.
4
Ductal lavage followed by observation versus oral corticosteroids in idiopathic granulomatous mastitis: A randomized trial.导管灌洗后观察与口服皮质类固醇治疗特发性肉芽肿性乳腺炎:一项随机试验。
Nat Commun. 2024 Oct 23;15(1):9144. doi: 10.1038/s41467-024-53143-2.
5
Diagnosis, Approach, and Clinical Classification of Idiopathic Granulomatous Mastitis: Consensus Report.特发性肉芽肿性乳腺炎的诊断、诊疗方法及临床分类:共识报告
Breast Care (Basel). 2024 Oct;19(5):243-251. doi: 10.1159/000541482. Epub 2024 Sep 18.
6
Idiopathic Granulomatous Mastitis as a Benign Condition Mimicking Inflammatory Breast Cancer: Current Status, Knowledge Gaps and Rationale for the GRAMAREG Study (EUBREAST-15).特发性肉芽肿性乳腺炎作为一种酷似炎性乳腺癌的良性疾病:现状、知识空白及GRAMAREG研究(EUBREAST - 15)的理论依据
Cancers (Basel). 2024 Oct 3;16(19):3387. doi: 10.3390/cancers16193387.
7
>Efficacy of disease-modifying antirheumatic drugs in the treatment of granulomatous mastitis: a systematic review.疾病修饰抗风湿药物治疗肉芽肿性乳腺炎的疗效:系统评价。
Rheumatol Int. 2024 Nov;44(11):2371-2379. doi: 10.1007/s00296-024-05719-w. Epub 2024 Sep 16.
8
Treatment modalities for granulomatous mastitis, seeking the most appropriate treatment with the least recurrence rate: a systematic review and meta-analysis.肉芽肿性乳腺炎的治疗方式:寻求复发率最低的最适宜治疗方法:系统评价和荟萃分析。
Eur J Med Res. 2024 Mar 12;29(1):164. doi: 10.1186/s40001-024-01761-3.
9
Imiquimod as a new treatment in refractory idiopathic granulomatous mastitis: report of two cases.咪喹莫特治疗难治性特发性肉芽肿性乳腺炎:两例报告。
Daru. 2024 Jun;32(1):443-447. doi: 10.1007/s40199-023-00501-y. Epub 2023 Dec 28.
10
Factors Affecting Recurrence of Idiopathic Granulomatous Mastitis: A Systematic Review.影响特发性肉芽肿性乳腺炎复发的因素:系统评价。
Breast J. 2023 Sep 26;2023:9947797. doi: 10.1155/2023/9947797. eCollection 2023.